Physician profile
David Chorley
NPI 1154386928
$2,773.58
in general payments reported to CMS, 2019-2025
38 companies · $898 in 2025
The $898 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.34 · 2020: $63.08 · 2021: $330 · 2022: $310 · 2023: $444 · 2024: $685 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,027.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $285.54 | 2023-2025 | Azstarys |
| Janssen Pharmaceuticals, INC | $283.40 | 2022-2025 | Spravato, Invega Sustenna |
| Abbvie INC. | $254.01 | 2022-2025 | Vraylar, Rinvoq |
| Xeris Pharmaceuticals, INC. | $228.77 | 2021-2023 | Keveyis |
| Otsuka America Pharmaceutical, INC. | $170.65 | 2022-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $166.76 | 2023-2025 | Caplyta |
| Alkermes, INC. | $163.98 | 2021-2025 | Aristada, Lybalvi |
| Almatica Pharma LLC | $117.13 | 2024-2025 | Loreev Xr |
| Vanda Pharmaceuticals INC. | $110.96 | 2024-2025 | Fanapt |
| Glaxosmithkline, LLC. | $95.29 | 2021-2025 | Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $74.25 | 2024-2025 | Cobenfy |
| Strongbridge US INC. | $63.08 | 2020 | |
| Novo Nordisk INC | $62.25 | 2021-2023 | |
| Madrigal Pharmaceuticals | $54.74 | 2025 | Rezdiffra |
| Exact Sciences Corporation | $52.38 | 2023-2024 | Cologuard Collection Kit |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $50.32 | 2024-2025 | Eterna, Freestyle Libre 3 |
| Amgen INC. | $45.59 | 2021-2022 | |
| Intra-Sana Laboratories | $45.58 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Pfizer INC. | $42.64 | 2021 | |
| Sanofi-Aventis U.S. LLC | $38.87 | 2021 | |
| Astellas Pharma US INC | $32.08 | 2023 | Veozah |
| Lundbeck LLC | $32.04 | 2023-2025 | Rexulti |
| Neuronetics, INC. | $27.53 | 2024 | Neurostar Tms Therapy System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.63 | 2019 | |
| Alnylam Pharmaceuticals INC. | $26.59 | 2022 | |
| Irhythm Technologies, INC. | $25.59 | 2024 | Zio Monitor, Zio Xt Patch |
| Currax Pharmaceuticals LLC | $24.36 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $20.36 | 2025 | Neffy |
| Welch Allyn | $19.97 | 2021 | |
| Pharmacosmos Therapeutics INC. | $17.02 | 2022 | |
| Dexcom, INC. | $16.98 | 2023 | Dexcom G6 Transmitter |
| Indivior INC. | $15.71 | 2019 | |
| Eisai INC. | $14.56 | 2021 | |
| Axsome Therapeutics, INC. | $14.36 | 2025 | Auvelity |
| Astrazeneca Pharmaceuticals Lp | $14.24 | 2025 | Airsupra |
| Siemens Medical Solutions USA, INC. | $14.02 | 2024 | Advia Chemistry Xpt System |
| Biohaven Pharmaceutical Holding Company Ltd. | $13.90 | 2022 | |
| Lilly USA, LLC | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chorley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.